Cambridge Healthtech Institute’s Second Annual

PCR for Molecular Medicine

Integrating Approaches for Clinical Success

February 16-18, 2015 | Moscone North Convention Center | San Francisco, CA
Part of the 22nd Annual Molecular Medicine Tri-Conference


About the Conference:

Polymerase chain reaction (PCR) is a staple in diagnostic labs worldwide with applications ranging from cancer to infectious diseases. Today, advances in PCR have sparked innovation, expanded research capabilities, and made the technology more clinically useful than ever. Cambridge Healthtech Institute's Second Annual PCR for Molecular Medicine will emphasize integrated approaches for PCR, from traditional to digital PCR for Molecular Medicine will provide a comprehensive look at PCR in both the research and clinical setting as well as insight into advanced techniques and tools for effective disease diagnosis.

Who Should Attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Diagnostics, Business Development, R&D, Chemistry, Clinical Research, Personalized Healthcare, Process Development, and Oncology.


Are There Limits to the Performance and Speed of PCR?

Carl T. Wittwer, M.D., Ph.D., Professor, Pathology, University of Utah


MTIDx: Multiple Target Identification Diagnostics

Hong Cai, Ph.D., CEO, Mesa Tech International, Inc.

Talk Title to be Announced

Andrew I. Brooks, COO and Director, Technology Development, RUCDR Infinite Biologics; Rutgers University

Not All Primers Are Created Equal: Priming Efficiency Bias Uncovered by NGS

Jian Han, Ph.D., Faculty Investigator, iCubate, HudsonAlpha Institute for Biotechnology


Digital PCR for Patient Monitoring and Stratification in Clinical Trials

Reinhold Pollner, Ph.D., Director, Clinical Trial Assay Development, Genoptix Medical Laboratory (a Novartis Company)

Evaluation of EGFR Mutations in Plasma from NSCLC Patients: Utility in Managing Patients on TKI Therapy

Chris Karlovich, Ph.D., Principal Scientist, Molecular Diagnostics, Clovis Oncology


An Automated Genetic Analysis Instrument That Boasts High Multiplexing Capabilities and Low Hands-On Time

Hanyoup Kim, Ph.D., Senior Scientist, Canon U.S. Life Sciences, Inc.

Droplet Digital PCR and Methylation Specific Quantitative Melt Analysis – Applications in Fragile X-Related Disorders and Beyond

David Godler, Ph.D., Senior Research Fellow, Cyto-molecular Diagnostics Research and Victorian Clinical Genetics Services; Head, The FMR1 Related Disorders Group, Murdoch Children’s Research Institute, Royal Children's Hospital


Universal Digital High-Resolution Melt: A Rapid Molecular Approach for Accurately Resolving Mixed Infections

Stephanie I. Fraley, Ph.D., Assistant Professor, Bioengineering, University of California San Diego

“Salvage Microbiology”—Identifying Pathogens in Culture Negative Infections

Robert A. Bonomo, M.D., Chief, Medical Service, Louis Stokes Cleveland VA Hospital; Vice Chair, Veterans Affair, Medicine, University Hospital Case Medical Center


Single-Tube Enrichment of Mutations in Cancer Gene Panels Using COLD-PCR Prior to Targeted Amplicon Resequencing

G. Mike Makrigiorgos, Ph.D., Professor, Radiation Oncology, Dana Farber and Harvard Medical School

Evaluation of Biofluid Derived Extracellular Vesicles in Brain Tumors

Leonora Balaj, Ph.D., Researcher, Massachusetts General Hospital, Harvard Medical School

For more details on the conference, please contact:
Samantha Lewis
Conference Director
Cambridge Healthtech Institute
T: (+1) 781-972-5461

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483

Joseph Vacca (Companies L-Z)
Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431


  2015 Plenary Sessions 

2015 MMTC Prelim Agenda 

Premier Sponsors:


Jackson Laboratory - small logo 

Leica Biosystems 




Thomson Reuters-Large 

Local Partners:




City of SSF